Related Experiment Video
Updated: Feb 6, 2026

Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay
Published on: September 16, 2012
Protective Efficacy of Candidate Vaccines Prior to Human Clinical Trials
1Sanofi Pasteur, Analytical Research and Development North America, Toronto, Ontario M2R 3T4, Canada.
Abstract:
Immunization of animals is one of the key standards for evaluation of vaccine efficacy prior to human clinical trials. However, vaccine organizations should not over-interpret these results as protective efficacy in animals may not be relevant in humans. Screening of vaccine candidates has recently been performed by several in vitro human models. A properly designed in vitro approach opens new venues for vaccine development.
More Related Videos
04:53A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
06:32Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Vaccinations
Statistical Software for Data Analysis and Clinical Trials
Trial and Error and Algorithm
Self-Efficacy